Cytori Therapeutics (United States)
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, United States. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cytori Therapeutics (United States), United States, covering academic research published from 2005 to 2018. Read More.
Open Access Percentage
27%
Total
Publications
56
Total Open
Publications
15
Total
Citations
5.5K
Open Access
Percentage
27%
Total
Publications
56
Total Open
Publications
15
Total
Citations
5.5K
Breakdown
Publisher Open
13%
Both
5%
Other Platform Open
9%
Closed
73%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 10%
1
Hybrid 20%
2
No Guarantees 70%
7
Other Platform Open
Domain 88%
7
Institution 13%
1
Preprint 0%
0
Public 0%
0
Other Internet 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 7 |
Europe PMC | Domain | 7 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 1 |
KU Leuven - Lirias | Institution | 1 |